1. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014;132(12):1453–60.
2. Xu C, Zhu L, Chan T, Lu X, Shen W, Madigan MC, et al. Chloroquine and hydroxychloroquine are novel inhibitors of human organic anion transporting polypeptide 1A2. J Pharm Sci. 2016;105(2):884–90.
3. Marmor MF. Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol. 2012;130(4):461–9.
4. Latasiewicz M, Gourier H, Yusuf IH, Luqmani R, Sharma SM, Downes SM. Hydroxychloroquine retinopathy: an emerging problem. Eye. 2017;31(6):972–6.
5. Pasadhika S, Fishman GA, Choi D, Shahidi M. Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity. Eye. 2010;24(5):756–63.